These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19482698)

  • 1. Transforming growth factor-beta in systemic sclerosis (scleroderma).
    Varga J; Whitfield ML
    Front Biosci (Schol Ed); 2009 Jun; 1(1):226-35. PubMed ID: 19482698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma.
    Ihn H
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):325-31. PubMed ID: 12455866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.
    Denton CP; Abraham DJ
    Curr Opin Rheumatol; 2001 Nov; 13(6):505-11. PubMed ID: 11698729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF beta--a role in systemic sclerosis?
    Cotton SA; Herrick AL; Jayson MI; Freemont AJ
    J Pathol; 1998 Jan; 184(1):4-6. PubMed ID: 9582519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts.
    Leask A; Abraham DJ; Finlay DR; Holmes A; Pennington D; Shi-Wen X; Chen Y; Venstrom K; Dou X; Ponticos M; Black C; Bernabeu C; Jackman JK; Findell PR; Connolly MK
    Arthritis Rheum; 2002 Jul; 46(7):1857-65. PubMed ID: 12124870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis: an update.
    Varga J
    Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of scleroderma. Collagen.
    Jimenez SA; Hitraya E; Varga J
    Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis.
    Leask A
    Pharmacol Res; 2011 Jun; 63(6):502-3. PubMed ID: 21315153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
    Usategui A; del Rey MJ; Pablos JL
    Expert Rev Clin Immunol; 2011 Jul; 7(4):491-8. PubMed ID: 21790292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
    McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
    Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
    Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of connective tissue synthesis in systemic sclerosis.
    Varga J; Bashey RI
    Int Rev Immunol; 1995; 12(2-4):187-99. PubMed ID: 7650421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosis.
    Ghosh AK; Bhattacharyya S; Lafyatis R; Farina G; Yu J; Thimmapaya B; Wei J; Varga J
    J Invest Dermatol; 2013 May; 133(5):1302-10. PubMed ID: 23303459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.
    Verrecchia F; Mauviel A; Farge D
    Autoimmun Rev; 2006 Oct; 5(8):563-9. PubMed ID: 17027893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
    Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
    Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.
    Sargent JL; Whitfield ML
    Expert Rev Clin Immunol; 2011 Jul; 7(4):463-73. PubMed ID: 21790289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
    Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
    Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
    Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
    Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
    Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.